Zimmer Biomet
ZBH
1,030 hedge funds and large institutions have $26.9B invested in Zimmer Biomet in 2023 Q2 according to their latest regulatory filings, with 112 funds opening new positions, 356 increasing their positions, 327 reducing their positions, and 70 closing their positions.
60% more first-time investments, than exits
New positions opened: 112 | Existing positions closed: 70
60% more call options, than puts
Call options by funds: $91.2M | Put options by funds: $57.1M
33% more funds holding in top 10
Funds holding in top 10: 9 → 12 (+3)
13% more capital invested
Capital invested by funds: $23.9B → $26.9B (+$3.07B)
4% more funds holding
Funds holding: 993 → 1,030 (+37)
9% more repeat investments, than reductions
Existing positions increased: 356 | Existing positions reduced: 327
0.77% more ownership
Funds ownership: 87.95% → 88.72% (+0.77%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$240M |
| 2 |
BlackRock
New York
|
+$149M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$121M |
| 4 |
Amundi
Paris,
France
|
+$96.4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$66.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$276M |
| 2 |
Millennium Management
New York
|
-$237M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$164M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$142M |
| 5 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
-$118M |
ZBH Hedge Fund Activity: Q2 2023 in Review
1,030 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2023, worth a combined $26.9B — up 13% from $23.9B a quarter earlier.
Buyers outnumbered sellers: 112 funds opened new ZBH positions and 70 closed out — a net gain of 42 holders — while 356 added to existing stakes and 327 trimmed.
The largest buyer was Invesco, adding an estimated $240M. The largest seller was Longview Partners, exiting entirely with an estimated $276M sold.
- 1,030 institutional investors held Zimmer Biomet (ZBH) as of Q2 2023, up from 993 in Q1 2023.
- Funds reported $26.9B of Zimmer Biomet stock for Q2 2023, up 13% quarter-over-quarter.
- 112 funds opened new Zimmer Biomet positions in Q2 2023 and 70 closed out, a net change of +42 holders.
- The largest Zimmer Biomet buyer in Q2 2023 was Invesco, an estimated $240M added.
- The largest Zimmer Biomet seller in Q2 2023 was Longview Partners, an estimated $276M sold.
Based on aggregated 13F filings for Q2 2023.